FDA goes easy on mobile apps?; CRO bets on pharma's thirst for analytics

> FDA affirms that only a fraction of medical apps would likely face regulatory review, a fresh sign that the agency is unlikely to stifle progress in mobile medicine. Item

> Bioanalytical CRO MedeoLinx has landed business from the 10 top drugmakers, which have sought analytics services to slice and dice genomics and clinical trials data. Report

> Better than Google ($GOOG)? Well, at least when it comes to online searches for rare diseases info, a team from the Technical University of Denmark believes that its FindZebra software trumps the web giant. Article

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.